Clinical trial
The Acute Optic Neuritis Network (ACON): a Non-interventional Prospective Multicenter Study on Diagnosis and Treatment of Acute Optic Neuritis
NCT05605951 is registered in ClinicalTrials.gov with Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Acute Optic Neuritis Network (ACON): a Non-interventional Prospective Multicenter Study on Diagnosis and Treatment of Acute Optic Neuritis
- Lead sponsor
- Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 15, 2020
- Completion date
- December 31, 2025
- Enrollment
- 200 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
demyelinating diseases, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder attack, optic neuritis